| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 42.5939 | 16 |
| GSM780708 | Untreated after 4 days (C2_1) | 39.0121 | 4 |
| GSM780709 | Untreated after 4 days (C3_1) | 43.4659 | 20 |
| GSM780719 | Untreated after 4 days (C1_2) | 42.7287 | 16 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.3004 | 19 |
| GSM780721 | Untreated after 4 days (C3_2) | 37.9043 | 2 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 43.7872 | 21 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 43.312 | 19 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 43.3066 | 19 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 45.0123 | 27 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 43.8472 | 21 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 39.871 | 6 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 42.339 | 15 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 41.8057 | 12 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 45.2921 | 29 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 43.4821 | 20 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 50.4219 | 50 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 44.3549 | 24 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 57.9398 | 63 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.653 | 20 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 40.5934 | 8 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 40.9542 | 9 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 41.5365 | 11 |